|
Martinez-Sanchez MV, Fuster JL, Campillo JA, Galera AM, Bermudez-Cortes M, Llinares ME, Ramos-Elbal E, Pascual-Gazquez JF, Fita AM, Martinez-Banaclocha H, Galian JA, Gimeno L, Muro M, Minguela A. Expression of NK Cell Receptor Ligands on Leukemic Cells Is Associated with the Outcome of Childhood Acute Leukemia. Cancers (Basel). 2021 May 11;13(10):2294. doi: 10.3390/cancers13102294. PubMed PMID: 34064810; PubMed Central PMCID: PMC8151902.
AÑO: 2021; IF: 6.575
|
34064810
|
Vasco-Mogorron MA, Campillo JA, Periago A, Cabanas V, Berenguer M, Garcia-Garay MC, Gimeno L, Soto-Ramirez MF, Martinez-Hernandez MD, Muro M, Minguela A. Blood-based risk stratification for pre-malignant and symptomatic plasma cell neoplasms to improve patient management. Am J Cancer Res. 2021 Jun 15;11(6):2736-2753. eCollection 2021. PubMed PMID: 34249425; PubMed Central PMCID: PMC8263680.
AÑO: 2021; IF: 5.942
|
|
Muro M, Llorente S, Gónzalez-Soriano MJ, Minguela A, Gimeno L, Alvarez-López MR. Pre-formed donor-specific alloantibodies (DSA) detected only by luminex technology using HLA-coated microspheres and causing acute humoral rejection and kidney graft dysfunction. Clin Transpl. 2006:379-83. PubMed PMID: 18365392.
AÑO: 2006
|
|
Gimeno L, Gonzalez-Lozano I, Soto-Ramirez MF, Martinez-Sanchez MV, Lopez-Cubillana P, Fuster JL, Martinez-Garcia J, Martinez-Escribano J, Campillo JA, Pons-Fuster E, Ferri B, Lopez-Abad A, Muro M, Minguela A. CD8+ T lymphocytes are sensitive to NKG2A/HLA-E licensing interaction: role in the survival of cancer patients. Oncoimmunology. 2021 Oct 14;10(1):1986943. doi: 10.1080/2162402X.2021.1986943. eCollection 2021. PubMed PMID: 34676148; PubMed Central PMCID: PMC8525952.
AÑO: 2021; IF: 7.723
|
|
Minguela A, Vasco-Mogorron MA, Campillo JA, Cabanas V, Remigia MJ, Berenguer M, Garcia-Garay MC, Blanquer M, Cava C, Galian JA, Gimeno L, Soto-Ramirez MF, Martinez-Hernandez MD, de la Rubia J, Teruel AI, Muro M, Periago A. Predictive value of 1q21 gain in multiple myeloma is strongly dependent on concurrent cytogenetic abnormalities and first-line treatment. Am J Cancer Res. 2021 Sep 15;11(9):4438-4454. eCollection 2021. PubMed PMID: 34659897; PubMed Central PMCID: PMC8493371.
AÑO: 2021; IF: 5.942
|